IPO Market Abuzz with Biotech Offerings

IPO Market Abuzz with Biotech Offerings “We can expect to see the first IPO take flight in mid-October and we are sticking with our prediction … of at least a dozen IPOs getting done before the end of the year.”

GE's Genomic Future

GE’s Genomic Future On its face, General Electric’s $9.5 billion stock purchase of Amersham is about imaging systems. But the more far-reaching consequences of the deal puts GE on the cutting edge of how new knowledge about genetics is used to treat patients. The deal could put General Electric in direct competition with diagnostic and […]

Get email updates

Get new actionable insights and updates from BiotechBlog